About 10 days ago, a 76-year-old male called you to tell you that his spiking blood sugars are higher than they have been in a long time. His blood sugars were in the 300-400 range. He used to never get much above 200. He reports that he has had no diet changes and is...
Orthostasis risk with SGLT-2 Inhibitors is a potential minor concern, particularly in our geriatric population. While a drop in blood pressure can be a good thing for a significant chunk of diabetes patients, that potential modest drop can lead to an increased...
What to do with an A1C ? For the experienced clinician, this is a very simple question, but I occasional see orders for A1C’s at a rate more frequently than every three months. Remember that it is basically an average blood sugar over a period of approximately...
In making some of these decisions about medication changes, there isn’t always a perfect answer, and people disagree, but I didn’t write this post to tell you that people disagree – hopefully most of you have figured that out by now! Anyway, here’s a brief overview of...
I’m going to cover sulfonylureas tonight; this class is a mainstay in the treatment Type 2 diabetes. Other than metformin, these drugs are probably the most frequent oral class used. The most frequent names that come to mind are glipizide, glimepiride, and...
